News From Top Investment Firms Worldwide

British Patient Capital and Mubadala Investment Company (Mubadala), an Abu Dhabi-based sovereign investor, have made a co-investment in the SV Biotech Crossover Opportunities Fund (SV BCOF) through the UK’s Life Sciences Investment Program (LSIP), a £200 million initiative launched in 2021 to support the growth of life sciences business in the UK. See here proivateequitywire. According to manager SV Health Investors, SV BCOF targets growth stage biotech companies developing transformative therapies and will focus on UK companies that have the potential to positively impact society by addressing key unmet clinical needs. British Patient Capital is a key investor in the fund and has committed a total of $48.6 million. To date, six investments have been completed through SV BCOF, including five in UK-based companies: Bicycle, a company developing a brand new class of precisely guided therapies to target intractable cancers; Quell Therapeutics, a specialist in engineered regulatory cell therapies for serious medical conditions driven by immune system overactivity; Pulmocide, a biopharmaceutical company that treats common but difficult-to-treat respiratory infections; and EyeBio, which is developing a new generation of eye disease therapies to protect, restore and improve vision for people who are underserved by available therapies.

Imbiba completes first £90m closure to support UK’s leading growing leisure, lifestyle and entertainment brands. Imbiba makes the new fund’s first investment in Little Houses Group, a series of desirable day care centers and family clubs. See the press release here. Imbiba, the UK’s leading leisure, lifestyle and entertainment investor in growth brands, has announced the first closure at around £70m of its new £90m fund and has completed its first investment in Little Houses Group. Led by significant investment from the British Business Bank through its Enterprise Capital Funds (ECF) programme, together with other investors including Asahi UK, the new fund will provide growth capital to support the expansion of leading leisure companies , lifestyle and entertainment.

Alternative investment manager Stonepeak Partners is looking to raise $2.5 billion (€2.3 billion) for its new infrastructure fund, which will target investment opportunities in North America and Europe, according to a report by IP&E Real Assets. See privateequitywire here. The report cites an investor meeting document that reveals that the Louisiana Teachers Retirement System has approved a $50 million commitment to the new Stonepeak Opportunities Fund. The fund is already in the process of acquiring a 50% stake in the Key Access Pipeline System, with completion of the acquisition expected by the end of the current quarter.

Employee Assistance Program (EAP) Platform

Mindtera, an Employee Assistance Program (EAP) platform in Indonesia, announced the closing of the combined seed and seed extension round with $850,000 funding led by East Ventures. See here technode. The round also saw commitments from Seedstars International Ventures among other major angel investors, Mindtera said in a statement on Monday. According to the company, the funding will be used to expand the reach of their business to business (B2B) operations to serve more customers and continuously develop their products in an effort to become the leading employee assistance program platform in Indonesia. Founded in 2021 by Tita Ardiati (Co-Founder & Chief Executive Officer) and Bayu Puspito Bhaskoro (Co-Founder & Marketing Director), Mindtera is a platform that uses data-driven insights to create a productive and happy workplace. The company manages the development, engagement and well-being of employees, following them from the hiring process to retirement.

Singapore-Based Logistics Firm

Singapore-based logistics firm Locad announced on Monday that it has raised an $11 million Series A financing round led by Reefknot Investments, a fund anchored by Temasek and logistics powerhouse Kuehne & Nagel. See here technode. The Series A funding round also featured returning investors Sequoia India and Southeast Asia’s Surge, Febe Ventures, Antler, as well as new investors Access Ventures, JG Summit and WTI, Locad said in a statement. Committed to democratizing the back-end (e)commerce supply chain, Locad will use the funds to build the largest order fulfillment network in the region. The company is adding warehouses, partnering with transport operators and hiring talent across the region to expand into Southeast Asia and Australia.

Beijing Ensonic Technology Co., Ltd. (hereinafter referred to as “Ensonic Technology”) announced that it has completed a B-round financing of nearly CNY 100 million. See equalocean here. The lead investor in this round is Fresh Capital, while Weed Ventures and Jin Quan also jointly participated in this investment round. Chang Weixi, a partner at Ensonic Technology, said this funding round will mainly be used for product research and development, marketing and other business directions. Ensonic Technology was founded in 2018 and completed 3 rounds of financing in 2018, 2019 and 2020. As an enterprise-wide acoustic AI technology service provider, Ensonic Technology has created a variety of equipment monitoring products and related service platforms through microphone arrays and acoustic systems signal processing capabilities, providing diversified solutions such as AI intelligent acoustic fault detection, operation and maintenance for energy, electric power and railway transportation customers.

Biotech company JHM Biopharma has announced that it has raised an additional CNY 100 million in Series A+ round just 3 months after the completion of Series A1 round. See Equalocean here. This round was co-led by Guangdian Capital and 3E Bioventures Capital. WinX Capital acted as exclusive financial advisor. Just 3 months earlier, JHM Biopharma completed a CNY 100 million Series A1 round to support its biological products for childhood genetic diseases, anti-aging, antivirus and new biological materials. Funds raised in this round will be used primarily for drug candidate pipeline research and development, reserve pipeline expansion, and construction of a commercial manufacturing base with GMP facility requirements.

This article is originally published on

Comments are closed.